Xeris Pharmaceuticals Inc (XERS) Annual Income Statement (USD)
XERS Quarterly Financials (USD)
Frequently Asked Questions About Xeris Pharmaceuticals Inc (XERS) Stock
Xeris Pharmaceuticals Inc's (XERS) last reported annual revenue was USD 163.91 Million.
Xeris Pharmaceuticals Inc's (XERS) annual revenue growth rate based on the revenue reported in the past 5 years is : 131.50%
Xeris Pharmaceuticals Inc's(XERS) is not profitable as of its last reported annual financials.
The net profit margin for Xeris Pharmaceuticals Inc's(XERS) from its laster reported year is -37.98%
The return on equity (ROE) for Xeris Pharmaceuticals Inc's(XERS) from its last reported annual financials is : -324.20%
The return on assets (ROA) for Xeris Pharmaceuticals Inc's(XERS) from its last reported annual financials is : -8.25%
The return on invested capital (ROIC) for Xeris Pharmaceuticals Inc's(XERS) from its last reported annual financials is : -20.54%
The Debt to Equity ratio for Xeris Pharmaceuticals Inc's(XERS) from its last reported annual financials is : -2815.28%
The dividend yield for Xeris Pharmaceuticals Inc's(XERS) from its laster reported year is 0.00%
Xeris Pharmaceuticals Inc's(XERS) has negative cash flow as of its last reported annual financials.
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Superior Revenue Growth
This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.
Superior Earnings Growth
This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.
High Gross Profit to Asset Ratio
This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.
What not to like
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Negative free cash flow
The company had negative total free cash flow in the most recent four quarters.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for XERS !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
Stocktwits
